Greg Stanton is pulling Google search traffic today, and the online conversation around him is not exactly a fan club meeting. Bluesky has seven posts on the Arizona Democrat in recent circulation, ranging from measles quarantines at an ICE detention facility in Eloy to a primary challenger calling him out by name and a voter urging the district to send him "onto the AIPAC trash heap." The financial record sitting in his public disclosure file is a separate story, one trade, one cannabis stock, one bad month of returns. Here's what Blind Trust has.
Why He's Trending
The social buzz around Stanton has three distinct flavors, none of them flattering. First: congressional staff and immigration-rights advocates flagged a measles quarantine at an ICE detention facility in Eloy, Arizona, inside Stanton's broader orbit as a House member from the Phoenix metro. Second: he's been rated an F on something called the Integrity Index, a fact his opponents are circulating with some enthusiasm. Third: a voter openly wants him replaced with someone who won't, in their framing, carry water for AIPAC.
There are no hard news stories in the last 24 hours driving this. Seven Bluesky posts and a trending spike. Sometimes the search interest arrives before the story does.
The One Trade
Here's what Blind Trust knows about Stanton's financial record: in the last 90 days, he filed exactly one disclosed stock trade. On May 6, 2026, he sold shares of TCNNF — Trulieve Cannabis, an over-the-counter cannabis company — in the $15,000 to $50,000 range.
One trade. One name. Trulieve Cannabis.
A member of the House Committee on Transportation and Infrastructure and the House Committee on Foreign Affairs selling a cannabis stock raises no committee-level conflict angle. Stanton doesn't sit on any committee with jurisdiction over cannabis regulation, DEA scheduling, or controlled substances.
The Alpha Record
Stanton's 30-day alpha on that single TCNNF sale: negative 19.4 percent versus the S&P 500. The record is 0 for 1.
To be precise about what that means: he sold Trulieve Cannabis, and in the 30 days after that sale, the stock underperformed the S&P 500 by 19.4 percentage points. The data set is one trade deep, which is the statistical equivalent of flipping a coin once and declaring yourself a forecaster.
What it does tell you: someone in the Arizona delegation was holding a cannabis company's OTC shares, decided to exit a position worth somewhere between $15,000 and $50,000, and filed the paperwork as required. Members are required to disclose. They are not required to explain why. The STOCK Act does not have a "tell us your reasoning" checkbox.
The Voting Record, For What It's Worth
Stanton has been active on the floor through the spring and summer of 2026. A quick tour through the relevant votes:
- He voted Yea on the TRIA Program Reauthorization Act of 2026 (H.R. 7128, June 29), which passed. TRIA reauthorizes the federal terrorism risk insurance backstop, relevant to the insurance and commercial real estate sectors, not to anything in Stanton's committee assignments.
- He voted Yea on the Financial Exploitation Prevention Act of 2025 (H.R. 2478, June 25), which passed. Also outside his committee lane — that's Financial Services Committee territory.
- He voted Yea on the 21st Century ROAD to Housing Act (H.R. 6644, June 23), which passed. Housing and infrastructure overlap here; Stanton does sit on Transportation and Infrastructure, though the housing-specific provisions are more squarely HUD territory.
- He voted Nay on H.R. 9238 (June 11), the FISA extension bill. It failed.
- He voted Nay on both the Veterans 2nd Amendment Protection Act (H.R. 1041) and the Sharri Briley and Eric Edmundson Veterans Benefits Expansion Act (H.R. 6047) on May 21, both of which passed.
- He voted Yea on the Fiscal Year 2025 Veterans Affairs Major Medical Facility Authorization Act (S. 2393, May 20), which passed.
- He voted Nay on the KIDS Act (H.R. 7757, June 29), which passed.
None of these votes overlap with the TCNNF cannabis sale. The vote-trade overlap table for Stanton is empty. No calendar proximity to flag, no committee jurisdiction to note.
The TCNNF Context
Trulieve Cannabis trades over the counter under the ticker TCNNF because U.S. cannabis companies can't list on major exchanges as long as the federal Controlled Substances Act treats marijuana as a Schedule I substance. That's a policy reality any sitting congressman is, at minimum, aware of as political context. Stanton doesn't sit on the Judiciary Committee, which handles scheduling policy, or Energy and Commerce, which handles FDA matters that could touch cannabis. His committee work is roads, airports, buildings, and foreign affairs.
His committee oversight and Trulieve Cannabis's regulatory future occupy two circles with meaningful distance between them. He held a cannabis stock. He sold it. It dropped hard afterward relative to the broader market.
The Political Backdrop
The Bluesky conversation around Stanton touches a primary challenge, a measles outbreak at a federal detention facility, and his AIPAC grades — none of which connect to the financial disclosure record. But when a politician starts trending for reasons adjacent to their integrity and independence, the financial record becomes the first place observers look. That's why Blind Trust exists.
What the record shows: one trade in 90 days, a cannabis company, a sale that preceded a 19-point underperformance. No committee conflict. No vote-trade timing to examine. A scored sample of one.
Stanton sits on Transportation and Infrastructure and Foreign Affairs. If you want to watch for real conflict-of-interest territory, those are the jurisdictions where a trade would carry actual weight — aviation, highways, transit, Western Hemisphere policy. His full disclosure record is public. The cannabis sale is the only entry in the last quarter.
The receipts are public. Make of them what you make of them.